Free Trial
→ $2 Trillion Disappears Because of Fed's Secretive New Move (From Stansberry Research) (Ad) Buy VRPX Stock  Free VRPX Stock Alerts

Virpax Pharmaceuticals (VRPX) SEC Filings & 10K Form

Virpax Pharmaceuticals logo
$1.61 -0.33 (-17.01%)
Closing price 04:00 PM Eastern
Extended Trading
$1.62 +0.01 (+0.37%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Virpax Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
03/21/2025
4:20 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
3:30 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2025
4:00 PM		Virpax Pharmaceuticals (Filer)
Form 424B4
01/27/2025
11:15 PM		Virpax Pharmaceuticals (Filer)
Form EFFECT
01/15/2025
3:31 PM		Virpax Pharmaceuticals (Filer)
Form S-1/A
01/08/2025
3:11 PM		Panis Jaydriane (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
3:30 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
3:47 PM		Virpax Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/30/2024
3:05 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
4:00 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:15 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
4:29 PM		Virpax Pharmaceuticals (Filer)
Form DEF 14A
11/29/2024
5:39 AM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
4:01 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
3:31 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
5:06 AM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
4:20 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
11:15 PM		Virpax Pharmaceuticals (Filer)
Form EFFECT
11/07/2024
4:01 PM		Virpax Pharmaceuticals (Filer)
Form S-1/A
10/28/2024
3:08 PM		Virpax Pharmaceuticals (Filer)
Form S-1/A
10/18/2024
4:28 PM		Virpax Pharmaceuticals (Filer)
Form S-1/A
10/10/2024
4:07 PM		Virpax Pharmaceuticals (Filer)
Form 10-K/A
10/10/2024
4:08 PM		Virpax Pharmaceuticals (Filer)
Form 10-K/A
10/09/2024
4:00 PM		Virpax Pharmaceuticals (Filer)
Form 8-K/A
10/04/2024
3:30 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:30 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:12 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
8:05 AM		Virpax Pharmaceuticals (Filer)
Form S-1/A
08/13/2024
6:35 AM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
4:26 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
3:30 PM		Virpax Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/26/2024
3:31 PM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
6:45 AM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
5:40 PM		Su Judy (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/15/2024
7:00 AM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:09 PM		Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2024
3:10 PM		Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
11:48 AM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
3:00 PM		Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2024
3:01 PM		Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2024
3:02 PM		Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s Great Society (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
07/09/2024
3:03 PM		Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
3:32 PM		Virpax Pharmaceuticals (Filer)
Form DEFA14A
07/08/2024
6:30 AM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
4:09 PM		Virpax Pharmaceuticals (Filer)
Form DEF 14A
06/12/2024
4:11 PM		Virpax Pharmaceuticals (Filer)
Form ARS
05/14/2024
11:15 PM		Virpax Pharmaceuticals (Filer)
Form EFFECT
05/13/2024
4:30 PM		Virpax Pharmaceuticals (Filer)
Form S-1/A
05/13/2024
3:02 PM		Virpax Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
8:54 PM		Virpax Pharmaceuticals (Filer)
Form S-1/A
04/30/2024
6:35 AM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
4:15 PM		Virpax Pharmaceuticals (Filer)
Form S-1/A
04/18/2024
3:17 PM		Virpax Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/26/2024
7:15 AM		Virpax Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
6:30 AM		Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:VRPX) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners
Your Wealth is Under Attack
Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...
American Alternative | Sponsored
A brutally honest economic warning for 2025 (see proof)
New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
DOGE officially begins retirement transformation
Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...
Altimetry | Sponsored
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
Ex CIA predicts 40% “double crash” – April 11
The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...
Paradigm Press | Sponsored